David Scheinberg
Company: Memorial Sloan Kettering Cancer Center
Job title: Chairman, Molecular Pharmacology
Seminars:
Panel Discussion: Advancing Beyond HLA 201 – strategies for Delivery to a Wider Patient Population 2:30 pm
day: Day One
Drugging Undruggable Cancer Targets with TCR Mimic Antibodies 11:30 am
day: Day One